News

This study evaluated stool-based DNA (sDNA) in 82 patients with colorectal cancer and 363 colonoscopically normal individuals using Exact’s version 2 technology. The study results were statistically consistent

The primary efficacy endpoint of statistical non-inferiority in the clinical cure rate at the test of cure visit was achieved. The study results showed that cethromycin cured 94%

The primary objective of the study is to determine the rate of durable complete response for tamibarotene therapy when administered as a single agent to adult patients with

At study end, pramlintide/metreleptin treatment reduced body weight on average by 12.7%, significantly more than treatment with pramlintide alone (8.4%). Subjects treated with pramlintide/metreleptin lost an average of

The new dressings, both in adhesive and non-adhesive versions, have been shown to lower the pH level of wounds. When wound pH is lowered, it has been shown

The initial clinical trial was a Phase I study of escalating single doses of the drug, G4544, in 30 normal volunteers. The endpoints of the study were to

The Phase I study will be an open label, multi-center dose escalation trial evaluating the safety and maximum tolerated dose of single or multiple dose administration of allogeneic

The program includes the COGENT-1 and COGENT-2 trials. COGENT (Clopidogrel and the optimization of gastrointestinal events trial) trials are designed to measure the incidence of upper gastrointestinal bleeding

Abilify is used for the treatment of pediatric patients aged 10 to 17 years old and diagnosed with bipolar I disorder, manic or mixed episode with or without